维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

共被期刊论文引用了1次 您的检索式：您选中1篇文献正在查看引证文献汇总

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer显示文摘Ovarian cancer is one of the most lethal malignant gynecological tumors.More than 70% of patients with ovarian cancer are diagnosed at advanced stage.The 5-year survival in patients with advanced ovarian cancer is less than 30% because of the lack of effective biomarkers for diagnosis,prognosis,and personalized treatment.MicroRNA(miR) is a class of small noncoding RNAs that negatively regulate gene expression primarily through post-transcriptional repression.Many studies on tissue miR in ovarian cancer have been carried out and show great potential in clinical practice.However,tissue samples are not easily available because sampling causes injury.Researchers have started to focus on plasma/serum miR,assuming that blood samples may replace tissue samples in miR research in the future.Plasma/serum miR research is still in its early stages.Studies on its function in the early diagnosis of ovarian cancer have achieved some progress,but plasma/serum miR profiling for prognosis and personalized treatment of ovarian cancer remains unknown.A thorough understanding of the function of plasma/serum miR in ovarian cancer will facilitate early diagnosis and improve treatment for ovarian cancer.	Hong Zheng Jia-Yu Liu Feng-Ju Song Ke-Xin Chen	2013	Cancer Biology & Medicine2013，10，3：	12

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费